Development and Validation of the Cluster Headache Screening Questionnaire.
- Author:
Pil Wook CHUNG
1
;
Soo Jin CHO
;
Byung Kun KIM
;
Soo Kyoung KIM
;
Mi Ji LEE
;
Yun Ju CHOI
;
Jeong Wook PARK
;
Byung Su KIM
;
Kyungmi OH
;
Heui Soo MOON
;
Tae Jin SONG
;
Danbee KANG
;
Juhee CHO
;
Chin Sang CHUNG
Author Information
- Publication Type:Original Article
- Keywords: cluster headache; diagnosis; migraine; prevalence; questionnaire; screening
- MeSH: Cluster Headache*; Diagnosis; Dihydroergotamine; Headache; Headache Disorders, Primary; Humans; Male; Mass Screening*; Migraine Disorders; Prevalence; Sensitivity and Specificity; Tension-Type Headache
- From:Journal of Clinical Neurology 2019;15(1):90-96
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND AND PURPOSE: Cluster headache (CH) is frequently either not diagnosed or the diagnosis is delayed. We addressed this issue by developing the self-administered Cluster Headache Screening Questionnaire (CHSQ). METHODS: Experts selected items from the diagnostic criteria of CH and the characteristics of migraine. The questionnaire was administered to first-visit headache patients at nine headache clinics. The finally developed CHSQ included items based on the differences in responses between CH and non-CH patients, and the accuracy and reliability of the scoring model were assessed. RESULTS: Forty-two patients with CH, 207 migraineurs, 73 with tension-type headache, and 18 with primary stabbing headache were enrolled. The CHSQ item were scored as follows: 3 points for ipsilateral eye symptoms, agitation, and duration; 2 points for clustering patterns; and 1 point for the male sex, unilateral pain, disability, ipsilateral nasal symptoms, and frequency. The total score of the CHSQ ranged from 0 to 16. The mean score was higher in patients with CH than in non-CH patients (12.9 vs. 3.4, p < 0.001). At a cutoff score of >8 points, the CHSQ had a sensitivity, specificity, positive predictive value, and negative predictive value of 95.2%, 96%, 76.9%, and 99.3%, respectively. CONCLUSIONS: The CHSQ is a reliable screening tool for the rapid identification of CH.
